| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |